Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lynx is an active Boston-based fintech company focused on bridging the gap between health and finance by providing an API-driven platform that enables health plans, financial institutions, and benefits administrators to embed customizable healthcare financial accounts and services into their user experiences. The company supports all major healthcare payment types—including consumer-directed health accounts like HSAs/FSAs—and offers advanced card issuance capabilities as well as e-commerce integration for qualified medical expenses. It recently raised $27 million in Series A funding led by Flare Capital Partners with participation from CVS Health Ventures and McKesson Ventures among others. Its mission is to make it easier for consumers to afford, engage with, and pay for healthcare through unified digital solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lynx Health Science.